Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT00850096

Public ClinicalTrials.gov record NCT00850096. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effects of Nasulin v.Placebo on Blood Glucose Control in Patients With Type 2 DM Treated With Basal Insulin & Oral Antidiabetic Meds, Excluding Secretagogues in Phase 2A, Randomized, Parallel, Double-Blind, Placebo-Controlled, Multi-Center Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is: * To assess the efficacy of Nasulin vs. placebo as indicated by time spent in euglycemia, assessed by continuous glucose monitoring data and serum fructosamine levels in patient volunteers with Type 2 Diabetes. * To asses the safety and tolerability of Nauslin at 50 IU and 100IU doses in patient volunteers with Type 2 Diabetes

Study identification

NCT ID
NCT00850096
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
CPEX Pharmaceuticals Inc.
Industry
Enrollment
94 participants

Conditions and interventions

Interventions

Other · Drug

Eligibility (public fields only)

Age range
18 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2009 (Type not available)
Primary completion
Mar 2010 (Actual)
Completion
Mar 2010 (Actual)
Last update posted
Dec 13, 2013

2009 – 2010

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
Radiant Research Chandler Arizona 85225 —
AMCR Institute, Inc Escondido California 92026 —
Scripps Whittier Diabetes Clinic La Jolla California 92037 —
Mills-Penninsula Health Services; Dorothy & Frank Diabetes Inst. San Mateo California 94401 —
Diablo Clinical Research Walnut Creek California 94598 —
Barbara Davis Center Aurora Colorado 80045 —
Clinical Research of West Florida Clearwater Florida 33765 —
University of Miami Diabetes Research Institute Miami Florida 33136 —
Metabolic Research Institute West Palm Beach Florida 33401 —
Atlanta Diabetes Associates Atlanta Georgia 30309 —
East-West Medical Research Institute Honolulu Hawaii 96814 —
Rocky Mountain Clinical Research Idaho Falls Idaho 83404-7596 —
Maine Research Associates Auburn Maine 04210 —
Washington University St Louis Missouri 63110 —
University of Rochester Rochester New York 14642 —
Mountain Diabetes and Endocrine Center Asheville North Carolina 28803 —
ECU Diabetes Research Center Greenville North Carolina 27834 —
Physician's East PA Greenville North Carolina 27834 —
Texas Diabetes and Endocrinology Austin Texas 78731 —
University of Texas; Southwestern Medical Center Dallas Texas 75390 —
Rainier Clinical Research Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00850096, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 13, 2013 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00850096 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →